2021-09-18
Sat
15:40-17:30
珠海厅7
腹部超声学组论坛（三）下半场 - 胆胰脾疾病超声研究进展
主持
(Host)
任小龙 Xiaolong Ren
泰康仙林鼓楼医院有限公司
15:40-15:55
“卫健委2019原发性肝癌诊疗规范”的超声解读
Ultrasonic interpretation of 2019 Health Commission guidelines for diagnosis and treatment of liver cancer
15:55-16:03
超声造影LI-RADS分类在小肝癌（≤3cm）诊断中的应用分析
The applicational value of LI-RADS of contrast-enhanced ultrasound in small hepatocellular carcinoma
16:03-16:11
多模态超声组学术前预测肝细胞癌微浸润的研究
Radiomics Model based on Multimodal Ultrasound for Pre-operative Prediction of Micro-invasion in Hepatocellular Carcinoma
16:11-16:19
超声造影LI-RADS M类分类标准的改变对其诊断效能的影响
Impact of revision of the LR-M criteria on the diagnostic performance of contrast-enhanced ultrasound LI-RADS
16:19-16:27
原发性肝癌超声造影定量血流灌注参数与病理特征的关系
Relationships of contrast-enhanced ultrasound blood perfusion parameters，differentiation and microangiogenesis of primary hepatic carcinoma
16:27-16:35
“示卓安”超声造影联合US-CT/MRI容积导航在肝肿瘤消融引导及评估中的价值研究
The combination of "Sonazoid" Contrast-enhanced Ultrasound and US-CT/MRI Navigation in Guidance and Evaluation of Liver Tumor Ablation
16:35-16:43
CEUS鉴别诊断肝炎背景上原发性和转移性肝癌
Contrast enhanced ultrasound identifies HCC and liver metastasis based on modified CEUS LI-RADS 2017
16:43-16:51
pH和超声响应的纳米造影剂通过自噬阻断治疗原发及转移性肿瘤的作用研究
PH and Nano Ultrasound Constrast Agent Research:Treat Primary and Metastaic Tumors by Autophagy
16:51-16:59
肝渡越时间及SWV在肝硬化门静脉高压患者门脉压力评估中的应用
Application values of hepatic transit time(HTT) and SWV in assessing portal pressure in patients with liver cirrhosis and portal hypertension
16:59-17:07
肝脏反应性淋巴组织增生与原发性小肝癌的超声造影表现及差异
Contrast-Enhanced Ultrasound features the difference between Hepatic Reactive Lymphoid Hyperplasia and Primary Small hepatic carcinoma
17:07-17:15
应用超声弹性成像评估门静脉-下腔静脉压力梯度在诊治门静脉高压症中的应用
The application of ultrasonic elastography in evaluating portal vein-inferior vena cava pressure gradient in the diagnosis and treatment of portal hypertension
17:15-17:23
超声和弹性成像诊断经颈静脉肝内门体分流术后支架功能障碍的研究
Diagnostic value of conventional ultrasound and shear wave elastography in detecting transjugular intrahepatic portosystemic shunt dysfunction